Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. (Q41835248)

From Wikidata
Jump to: navigation, search
scientific article published on 26 May 2016
edit
Language Label Description Also known as
English
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
scientific article published on 26 May 2016

    Statements

    Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. (English)
    1 reference
    Yvette Drew
    1 reference
    Jonathan Ledermann
    1 reference
    Geoff Hall
    1 reference
    Daniel Rea
    1 reference
    Ros Glasspool
    1 reference
    Martin Highley
    1 reference
    Gordon Jayson
    1 reference
    Julieann Sludden
    1 reference
    James Murray
    1 reference
    David Jamieson
    1 reference
    Sarah Halford
    1 reference
    Gary Acton
    1 reference
    Zoe Backholer
    1 reference
    Raffaella Mangano
    1 reference
    Alan Boddy
    1 reference
    Nicola Curtin
    1 reference
    Ruth Plummer
    1 reference
    26 May 2016
    1 reference
    114
    1 reference
    e21
    1 reference
    12
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit